Similar Articles
1131 Intermediate hepatocellular carcinoma: How to choose the best treatment modality?
1132 Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma
1133 Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells
1134 Hepatocellular carcinoma: From diagnosis to treatment
1135 Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma
1136 Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
1137 Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
1138 Management of recurrent hepatocellular carcinoma after liver transplant
1139 Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization
1140 Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA